Technologies related to Vaccine

Novel Human Rotavirus Vaccine CDC-6 Strain for Impacted Subgroup, the Lewis Negative Population
Ref: E-285-2015/0 | Updated: Mar 9, 2018
West Nile/Zika Virus Chimeras for Inactivated Zika Vaccine and Diagnostic Assay Development
Ref: E-177-2016/0 | Updated: Dec 21, 2017
Chimeric Dengue/Zika Viruses for Live-Attenuated Zika Vaccine Development
Ref: E-178-2016/0 | Updated: Dec 4, 2017
A Plasmid-deficient Chlamydia Trachomatis Strain, as a Safe, Immunogenic, and Protective Live Attenuated Vaccine For Blinding Trachoma
Ref: E-028-2012/0 | Updated: Dec 4, 2017
Neutralizing Antibodies to Influenza HA and Their Use and Identification
Ref: E-061-2016/0 | Updated: Oct 31, 2017
Extracellular Vesicles, Methods of Making Them, and Methods of Reducing Liver Uptake of Extracellular Vesicles
Ref: E-083-2016/0 | Updated: Dec 7, 2017
Monoclonal Antibodies that Neutralize Norovirus
Ref: E-226-2011/0 | Updated: Jan 26, 2017
Polyvalent Influenza Virus-Like Particles (VLPs) and Use as Vaccines
Ref: E-195-2014/0 | Updated: Dec 1, 2016
Conserved Element Vaccines for HIV
Ref: E-087-2015/0 | Updated: Aug 8, 2016
Prevention or Treatment of Viral Infections by Inhibition of the Histone Methyltransferases EZH1/2
Ref: E-141-2015/0 | Updated: Aug 10, 2015
Recombinant Paramyxoviruses Expressing Optimized Heterologous Antigens
Ref: E-241-2014/0 | Updated: Jun 27, 2017
Live Attenuated Japanese Encephalitis Virus Vaccine
Ref: E-231-2014/0 | Updated: Jul 1, 2015
A Novel Virus-Based Expression System
Ref: E-181-2014/0 | Updated: Aug 18, 2015
Brachyury-directed Vaccine for the Prevention or Treatment of Cancers
Ref: E-055-2011/0 | Updated: Oct 23, 2017
Novel Vaccine for Prevention and Treatment of Chlamydia Infection
Ref: E-133-2012/0 | Updated: Aug 11, 2015
Vaccine to Prevent BK Polyomavirus-associated Kidney and Bladder Infections in Organ Transplant Recipients
Ref: E-168-2011/0 | Updated: Nov 17, 2017
15kD Granulysin for Monocyte Differentiation: A New Immunotherapeutic for Both in vivo and ex vivo Applications
Ref: E-158-2009/0 | Updated: Oct 23, 2017
Novel Regulatory B cells for Treatment of Cancer and Autoimmune Disease
Ref: E-101-2010/0 | Updated: Sep 21, 2015
Use of a Modified Adaptor Molecule LAT to Improve Immunotherapy for Cancer and Other Diseases
Ref: E-159-2009/0 | Updated: Oct 23, 2017
Recombinant Vaccines Based on Poxvirus Vectors
Ref: E-552-1982/2 | Updated: Aug 18, 2015
Immunogenic Peptide from NGEP Protein for Developing Prostate Cancer Vaccines
Ref: E-042-2009/0 | Updated: Oct 23, 2017
Live Attenuated Vaccine to Prevent Disease Caused by West Nile Virus
Ref: E-357-2001/1 | Updated: Sep 10, 2015
Immunostimulatory Combinations of TLR Ligands and Methods of Use
Ref: E-298-2007/0 | Updated: Oct 23, 2017
Adoptive Immunotherapy with T Lymphocytes Engineered for Enhanced Survival
Ref: E-340-2004/2 | Updated: Oct 23, 2017
Vaccines and Methods of Treating Drug-Resistant HIV-1 and Hepatitis B Viruses
Ref: E-137-2003/1 | Updated: Oct 23, 2017
Subscribe to Technologies related to Vaccine